Welcome to our dedicated page for Cinemark Hldgs SEC filings (Ticker: CNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cinemark’s box-office swings, concession margins, and premium-format rollouts all show up first in its SEC filings. Whether you need the loyalty-program numbers buried in a Cinemark annual report 10-K simplified or want to confirm occupancy rates in the latest Cinemark quarterly earnings report 10-Q filing, this page delivers every disclosure the moment it hits EDGAR.
Stock Titan’s AI turns hundreds of pages into clear insights. Our engine tags key risk factors, extracts non-GAAP metrics, and surfaces Cinemark insider trading Form 4 transactions within seconds. You’ll see Cinemark Form 4 insider transactions real-time, plus side-by-side charts that link trading patterns to blockbuster release dates.
- 10-K & 10-Q – drill into segment revenue, concession profit, and lease obligations with AI highlights for faster Cinemark earnings report filing analysis.
- 8-K – get Cinemark 8-K material events explained, from new studio partnerships to premium-format expansions.
- Form 4 – monitor Cinemark executive stock transactions Form 4 to spot confidence signals from management.
- DEF 14A – our summaries of the Cinemark proxy statement executive compensation clarify pay-for-performance links.
Need context fast? Type a natural question—“Cinemark SEC filings explained simply” or “understanding Cinemark SEC documents with AI”—and our platform answers with concise language, not legalese. Real-time alerts, searchable text, and plain-English explanations mean professionals can track cash flow shifts, compare quarter-over-quarter ticket trends, or flag covenant changes without slogging through dense footnotes.
Cinemark Holdings, Inc. and Cinemark USA, Inc. filed a Current Report on Form 8-K disclosing a Fourth Amendment, dated September 5, 2025, to their Second Amended and Restated Credit Agreement originally dated May 26, 2023. The amendment follows three prior amendments (May 28, 2024; November 29, 2024; June 30, 2025) and names Barclays Bank PLC as administrative agent. The filing is signed by Michael D. Cavalier, Executive Vice President - General Counsel and Business Affairs & Secretary. The document identifies the parties as Cinemark Holdings, Inc., Cinemark USA, Inc., various lenders and agents, and Barclays Bank PLC. No specific financial terms, covenant changes, borrowing amounts, maturity changes or other economic details are included in the disclosed text.
Melissa Thomas, EVP and Chief Financial Officer of Cinemark Holdings, Inc. (CNK), reported an automatic sale of common stock under a Rule 10b5-1 trading plan. On 08/15/2025 she disposed of 7,200 shares at a weighted average price of $25.17 per share, leaving her with 203,768 shares beneficially owned. The Form 4 notes the 10b5-1 plan was adopted on September 4, 2024, so the sale occurred pursuant to pre-established instructions. The filing was signed by attorney-in-fact Michael Cavalier on 08/18/2025.
Cinemark Holdings, Inc. (CNK) filed a Form 8-K reporting a material event that includes an exhibit: a Warrant Unwind and Termination Agreement dated August 15, 2025. The filing identifies the registrant, its Delaware incorporation, SEC file number, principal address in Plano, Texas, and that Common Stock (CNK) is listed on the New York Stock Exchange. The document is signed by Michael D. Cavalier and dated August 18, 2025. The 8-K lists Exhibit 10.1 as the form(s) of the Warrant Unwind and Termination Agreement but does not disclose the agreement's terms, financial impact, counterparties, or other substantive transaction details.
Cinemark Holdings, Inc. (CNK) Form 144 filing for proposed sale of shares by an insider. The filing shows a proposed sale of 7,200 common shares through Charles Schwab & Co., Inc. on 08/15/2025, with an aggregate market value of $181,246.00 and total shares outstanding listed as 115,035,514. The securities were acquired via restricted stock lapses: 3,309 shares on 02/23/2023 and 3,891 shares on 02/20/2024, both identified as equity compensation from Cinemark Holdings, Inc. The filer previously sold 7,200 shares on 05/15/2025 yielding $226,340.00. The notice includes the signer’s representation about lack of undisclosed material adverse information.
Cinemark Holdings, Inc. is the subject of a Schedule 13G/A disclosing that Orbis Investment Management Limited and Allan Gray Australia Pty Ltd together beneficially own 10,098,174 shares of common stock, representing 8.8% of the class. Orbis reports sole voting and dispositive power over 10,045,947 shares while Allan Gray reports sole voting and dispositive power over 52,227 shares.
The filing classifies both reporting persons as non-U.S. institutions equivalent to investment advisers and states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting persons expressly disclaim being a group and disclaim beneficial ownership of each other’s shares.
Cinemark Holdings, Inc. reported that its Board of Directors has declared a dividend that will be paid during the third quarter of 2025. The Current Report states the announcement is summarized in a press release attached as Exhibit 99.1 titled "2Q25 Dividend Release," and the filing also includes a Cover Page Interactive Data File as Exhibit 104.
The filing does not state the dividend amount, the specific payment or record dates, the source of funds, or any related financial impact, and it includes no financial statements or earnings disclosure. The document identifies the companys common stock trading as CNK on the New York Stock Exchange and shows the emerging-growth-company checkbox as unchecked. Because key dividend terms are absent from this report, readers must consult the attached press release for complete details.
Form 4 filing for Cinemark Holdings (CNK) discloses that Chief Marketing & Content Officer Wanda Marie Gierhart sold 1,254 common shares on 1 Aug 2025 at $28.49 per share, a transaction value of roughly $35.7 k. The sale was executed automatically under a Rule 10b5-1 plan adopted 13 Mar 2025, limiting discretionary timing. After the trade, Gierhart still owns 92,754 shares, so only ~1.3 % of her holdings were liquidated. No derivative securities were involved.
The modest size relative to her remaining stake and the use of a pre-set trading plan suggest limited informational signal for investors. The filing does not indicate any change in role or additional corporate events.